Stop Taking Nan Bao!

HealthPharmacy
Last updated on
Avatar photo
By Bryan Tan Van Hong

Publicity Associate at YPC. Currently working in Esyms, an online pharmacy platform and Registered Pharmacist at a retail pharmacy. Oh, and not to forget, pun enthusiast.

If you are one of those who consumes ‘Nan Bao’ capsules, be aware that the Health Ministry’s National Pharmaceutical Regulatory Agency (NPRA) has released a statement that all sellers and distributors of this traditional supplement to stop all sales and distribution as it is against the Sale of Drugs Act 1952 and the Control of Drugs and Cosmetics Regulations 1984.

These capsules are found to contain sildenafil and tadalafil, both which are ingredients used medically to treat erectile dysfunction. These medication can only be obtained via a prescription from a doctor. Supplements containing these are not allowed to be classified as traditional.

“The use of sildenafil and tadalafil without a doctor’s advice can cause serious adverse effects such as impairment of vision and hearing, low blood pressure, and effects to the cardiovascular systems such as stroke and heart attack.” The misuse of these medication can prove to be dangerous especially those who consume medication containing nitrates.

If you had tried taking or is currently taking “Nan Bao” supplements, visit your nearest doctor or pharmacist if you experience any discomfort.

Related

Written by Bryan Tan – Marketing and Communications Associate at YPC, currently a PRP at a retail pharmacy, and pun enthusiast   Malaysia is one of the countries with a high prevalence of diabetic patients. Malaysia is also a country which majority of its citizens observe the Ramadhan fast every year. Diabetic patients who fast…

Starting from 1 January 2019, all applications for pharmacy licenses and permits will be associated with a newly imposed fee. The amendments are as follow: “I) Di bawah Peraturan 28 Peraturan-Peraturan Racun (Pindaan) 2018 iaitu :  28. (1) An Application for a licence under the Act shall be accompanied by the following fees:    …

Recall of Losartan

Last updated on

On early March, the Ministry of Health Malaysia released a statement regarding the recall of 7 types of medication containing the active ingredient Losartan. This came about after some of these angiotension II receptor blocker (ARB) were found to contain unacceptable amount of nitrosamine, a substance which is possibly carcinogenic, or has the potential to…

Stable Coronary Artery Disease (2nd Edition)

Last updated on
The previous clinical practice guidelines for the management of stable angina were issued in 2010. Since then, there have been advances in both diagnostic and therapeutic strategies in the management of this progressive disease. Therefore, it is timely for the publication of this CPG, with a title that is now evolved from stable angina to...

Written by Tang Jia Wen, commitee member of MCPS 2.5   On 27 July 2019, the Malaysian Clinical Pharmacy Symposium (MCPS) 2.5 – A Cancer Therapy Counselling Workshop was held in International Medical University (IMU). It had successfully gathered pharmacists from different backgrounds and provided a conducive platform for them to exchange ideas and thoughts…

NDMA Found in Ranitidine

Last updated on

Written by Bryan Tan – Marketing and Communications Associate at YPC, currently a PRP at a retail pharmacy, and pun enthusiast   Recently, there has been news regarding the discovery of traces of N-Nitrosodimethylamin (NDMA) found in ranitidine medications. This was reported by the American-based Food and Drug Administration (FDA) as well as the Singaporean…

Others

Remdesivir in Malaysia As everyone eagerly awaits results from clinical trials regarding treatment and vaccination option(s) for COVID-19, a possible “knight in shining armour” emerges: Remdesivir. Remde-saviour? Currently, the medication is undergoing 6 separate clinical trials for COVID-19: 2 initiated by Gilead (the manufacturer) (moderate & severe manifestations) 2 by health authorities in China (mild/moderate...
In conjunction with World Contraception Day (WCD) which takes place on 26th of September every year, Bayer Co (Malaysia) has launched a chatbot named Ask Maya to empower women to ensure every pregnancy is wanted, every childbirth safe and every girl`s potential fulfilled. The 'Ask Maya' chatbot initiative has been made possible through Bayer's partnership with the Federation of Reproductive...

A Foreword by Dr Mai Chun-Wai

Last updated on

2018 was an exciting year for us. During this year’s Annual Business Meeting, a new steering committee structure was approved by the members of MPS-YPC, which we have then expanded our service. In the past, MPS-YPC developed series of continuous professional development (CPD) for the young pharmacists. In 2018, we have expanded the collaboration with…

A Foreword by Cedric Chua: #ForwardTogether2020

Last updated on

The past decade had been transformative for MPS-YPC. From the relentless championing of young pharmacist issues to the birth of a myriad of initiatives to add value to this group, MPS-YPC had redefined how young pharmacists advocate, connect and develop in an ever changing healthcare industry. Today, fueled by a fast-expanding presence that spreads across…

On October 6, YPC held its annual innovative healthcare symposium for the third successive year. This year’s theme was ‘Healthcare 4.0: Closing the Gap Between Patients & Technology’. Via this platform, MPS-YPC hopes to increase awareness and interest in the advancement of technology in current healthcare settings. We had the honour of our very own…

Malaysia ranked #1 on Healthcare Index Score

Last updated on

In the beginning of 2019, lifestyle and living website International Living published its list of the World’s Best Place to Retire in 2019. The list was started 29 years ago and is still being updated every single year since then. With a huge team which covers 5 continents, its research and methodologies are second to…